Journal
AUTOIMMUNITY REVIEWS
Volume 15, Issue 3, Pages 236-241Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.autrev.2015.11.008
Keywords
Type 1 diabetes; Regulatory T-cell immunotherapy; beta-Cells
Categories
Ask authors/readers for more resources
Type 1 diabetes (T1D) is a chronic autoimmune disease characterized by the loss of insulin-producing pancreatic beta-cells. The pathogenesis of T1D is complex and multifactorial and involves a genetic susceptibility that predisposes to abnormal immune responses in the presence of ill-defined environmental insults to the pancreatic islets. This review discusses how adaptive immunoregulatory T cells contribute to the modulation of the development and evolution of T1D, together with potential approaches that target these cells for new therapies in the disease. (C) 2015 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available